Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

DLHIX vs SCHLX overlap: 44% of top holdings shared

Bottom line

How much do DLHIX and SCHLX overlap?

44% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 38.8% of DLHIX's assets and 47.2% of SCHLX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

DLHIXSCHLX
Weight overlap (top 25)44%
Shared holdings12
Weight in shared holdings38.8%47.2%
Total positions10865
Expense ratio0.96%1.06%
Holdings as ofJun 30, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Holdings DLHIX and SCHLX have in common

Holding% of DLHIX% of SCHLXOverlap
Abbvie Inc ABBV4.19%4.90%4.19%
Eli Lilly & Company LLY4.16%13.85%4.16%
Regeneron Pharmaceuticals Inc REGN3.91%1.43%1.43%
Unitedhealth Group Inc UNH3.88%5.73%3.88%
Pfizer Inc PFE3.84%1.17%1.17%
Merck & Company Inc MRK3.68%4.85%3.68%
Gilead Sciences Inc GILD3.54%2.78%2.78%
Astrazeneca Plc AZN3.27%3.80%3.27%
Roche Holding Ag ROP3.01%1.24%1.24%
Amgen Inc AMGN2.27%2.88%2.27%
Vertex Pharmaceuticals Inc VRTX1.66%2.45%1.66%
Boston Scientific Corp BSX1.42%2.10%1.42%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in DLHIX

  1. Ucb Sa — 5.19%
  2. Elevance Health Inc — 3.25%
  3. Chugai Pharmaceutical Co Ltd — 2.77%
  4. Viatris Inc — 2.48%
  5. Oruka Therapeutics Inc — 2.41%
  6. Halozyme Therapeutics Inc — 2.30%
  7. Illumina Inc — 2.11%
  8. Alkermes Plc — 1.82%
  9. Viking Therapeutics Inc — 1.72%
  10. Roivant Sciences Ltd — 1.60%
  11. Neurocrine Biosciences Inc — 1.57%
  12. Arcus Biosciences Inc — 1.56%
  13. Zimmer Biomet Holdings Inc — 1.42%

Only in SCHLX

  1. Johnson & Johnson — 6.19%
  2. Thermo Fisher Scientific Inc — 3.46%
  3. Novartis AG — 2.90%
  4. Intuitive Surgical Inc — 2.69%
  5. Stryker Corp — 2.61%
  6. Abbott Laboratories — 2.39%
  7. Danaher Corp — 2.13%
  8. McKesson Corp — 2.05%
  9. Novo Nordisk A/S — 1.73%
  10. Medtronic PLC — 1.54%
  11. Bristol-Myers Squibb Co — 1.50%
  12. Cardinal Health Inc — 1.34%
  13. Cencora Inc — 1.26%

Asset mix

Asset typeDLHIXSCHLX
Stocks94.8%99.6%
Preferred stock3.0%—
Cash & short-term funds2.0%0.5%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Country mix

CountryDLHIXSCHLX
US75.4%85.7%
CH3.0%5.2%
BE5.2%—
GB3.3%3.8%
IE3.2%1.5%
JP2.8%—
FR2.0%1.0%
DK—1.7%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Check another pair

FAQ

How much do DLHIX and SCHLX overlap?
About 44% by weight. 12 securities appear in both funds' top 25 holdings; they make up 38.8% of DLHIX's assets and 47.2% of SCHLX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do DLHIX and SCHLX have in common?
The largest shared holdings are Abbvie Inc, Eli Lilly & Company, Unitedhealth Group Inc, Merck & Company Inc, Astrazeneca Plc.
Should I own both DLHIX and SCHLX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, DLHIX or SCHLX?
DLHIX is broader, with 108 positions versus 65 for SCHLX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.